ScoreWhy is Anuh Pharma Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 14.56% and Operating profit at 16.15% over the last 5 years
2
Negative results in Dec 24
- PBT LESS OI(Q) At Rs 12.33 cr has Fallen at -20.3 %
- PAT(Q) At Rs 10.34 cr has Fallen at -29.9 %
3
Stock is technically in a Bearish range
- The technical trend has deteriorated from Mildly Bearish on 07-Apr-25 and has generated 4.36% returns since then
- Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
4
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
5
Underperformed the market in the last 1 year
- Even though the market (BSE 500) generated negative returns of -1.07% in the last 1 year, its fall in the stock was much higher with a return of -26.11%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Anuh Pharma for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Anuh Pharma
-26.11%
-0.65
40.01%
SENSEX
0.45%
0.02
14.48%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
14.56%
EBIT Growth (5y)
16.15%
EBIT to Interest (avg)
37.64
Debt to EBITDA (avg)
0.58
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.96
Tax Ratio
20.79%
Dividend Payout Ratio
20.86%
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
19.39%
ROE (avg)
15.56%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
17
Industry P/E
33
Price to Book Value
2.77
EV to EBIT
15.06
EV to EBITDA
13.05
EV to Capital Employed
3.02
EV to Sales
1.28
PEG Ratio
NA
Dividend Yield
1.49%
ROCE (Latest)
23.53%
ROE (Latest)
16.58%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-10What is not working for the Company
PBT LESS OI(Q)
At Rs 12.33 cr has Fallen at -20.3 %
PAT(Q)
At Rs 10.34 cr has Fallen at -29.9 %
Loading Valuation Snapshot...
Here's what is not working for Anuh Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 12.33 cr has Fallen at -20.3 %
over average PBT of the previous four quarters of Rs 15.47 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 10.34 cr has Fallen at -29.9 %
over average PAT of the previous four quarters of Rs 14.76 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
